Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.
Secemsky, Eric A, Robert W Yeh, Laura Mauri, and DAPT Study Investigators. 2017. “Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.”. JACC. Cardiovascular Interventions 10 (14): 1468-69.